Clinical Trials Browser

Phase 2 × Pharmaceutical Preparations × Breast × Clear all

NCT06207734 2025-05-01

Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Phase 2 Terminated

64 enrolled 7 charts

Carcinoma, Ductal, Breast